资讯
Background Tobacco smoking is a leading behavioural risk factor for death in the UK, contributing to deaths from cardiovascular disease, chronic respiratory diseases and common infectious diseases. 1 ...
Background Exacerbations of respiratory conditions including asthma are amongst the most common causes of emergency hospital attendances, but numerous pulmonary and extra-pulmonary comorbidities can ...
The National Aspergillosis Centre, University Hospital of South Manchester, The University of Manchester, Manchester Academic Health Science Centre, Manchester, UK Correspondence to Dr Chris Kosmidis, ...
Background Social media may influence children and young people’s health behaviour, including cigarette and e-cigarette use. Methods We analysed data from participants aged 10–25 years in the UK ...
Background The integration of artificial intelligence (AI) into critical care offers significant potential to enhance early ...
3 National Heart and Lung Institute, Imperial College London and Royal Brompton Hospital, London, UK Correspondence to Professor Jennifer K Quint, National Heart and Lung Institute, Imperial College ...
Reduction of the risk of asthma attacks is a major goal of current asthma management. We propose to derive a risk scale predicting asthma attacks based on the blood eosinophil count and exhaled nitric ...
Correspondence to Dr Kirstie S Opstad, British Thoracic Society, London, UK; kirstie.opstad{at}brit-thoracic.org.uk; Dr Hazel J Evans; Hazel.Evans{at}uhs.nhs.uk The aim of the guideline was to provide ...
Introduction Identifying acute hypercapnic respiratory failure is crucial in the initial management of acute exacerbations of COPD. Guidelines recommend obtaining arterial blood samples but these are ...
Background Systemic sclerosis (SSc) is a heterogeneous disease with frequently associated interstitial lung disease (SSc-ILD). We aimed to determine the prognostic potential of phenotyping patients ...
Background Idiopathic pulmonary fibrosis (IPF) is a severe lung disease characterised by extensive pathological changes. The objective for this study was to identify the gene network and regulators ...
2 Research and Early Development, Respiratory and Immunology, BioPharmaceuticals RandD, AstraZeneca, Cambridge, UK 3 Respiratory and Immunology, Biometrics and Statistical Innovation, Late Respiratory ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果